A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer.

A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer.

Item
http://www.wikidata.org/entity/Q40358670
Sulindac-Derived RXRα Modulators Inhibit Cancer Cell Growth by Binding to a Novel SitePrevention of multidrug resistance (MDR) in osteosarcoma by NSC23925.In vitro anti-angiogenic properties of LGD1069, a selective retinoid X-receptor agonist through down-regulating Runx2 expression on Human endothelial cellsSynthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation.Rexinoids modulate steroid and xenobiotic receptor activity by increasing its protein turnover in a calpain-dependent manner.A selective retinoid X receptor agonist bexarotene (LGD1069, targretin) inhibits angiogenesis and metastasis in solid tumours.Novel strategies to prevent the development of multidrug resistance (MDR) in cancer.Cell proliferation inhibition and alterations in retinol esterification induced by phytanic acid and docosahexaenoic acid.
P2860

A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer.

Item
http://www.wikidata.org/entity/Q40358670
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A selective retinoid X recepto ...... e in advanced prostate cancer.
@en
type
label
A selective retinoid X recepto ...... e in advanced prostate cancer.
@en
prefLabel
A selective retinoid X recepto ...... e in advanced prostate cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
A selective retinoid X recepto ...... e in advanced prostate cancer.
@en
P2093
P304
P31
P356
P433
P478
P577
P698
P921